The newly approved over-the-counter CGM offers a new approach to tackling childhood obesity but also raises a host of ...
Senseonics is bringing the commercialization and distribution of its continuous glucose monitor products back in-house. The Germantown, MD-based company said it has signed a Memorandum of ...
Continuous glucose monitoring (CGM) devices may overestimate blood glucose levels in healthy adults, potentially leading to unnecessary dietary changes and confusion among users, according to a recent ...
Introducing continuous glucose monitoring in primary care optimizes diabetes management in underserved populations.
The FDA has approved San Diego, California-based Dexcom for a Bluetooth-enabled continuous glucose monitor (CGM), called the G5 Mobile CGM system. Correction: A previous version of this article ...
Ultrahuman has launched the new M2 Live glucose monitoring platform, which doesn't require a subscription and is cheaper than the M1 Live.
New research from Montefiore Einstein investigators reveals that an underutilized tool, more commonly employed by ...
A Japanese study conducted by a team from Nagoya University Graduate School of Medicine found that the use of continuous glucose monitoring (CGM) devices, equipped with sensors that alert diabetics ...
FDA clears Dexcom Stelo as the first OTC CGM for children, raising new questions around app access, caregiver oversight, school device rules, and reimbursement.
Total healthcare costs were significantly lower among adults with diabetes who used continuous glucose monitoring (CGM) systems compared to those who did not use CGM, according to a December study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results